123 related articles for article (PubMed ID: 25476515)
21. Molecular characterizations of glioblastoma, targeted therapy, and clinical results to date.
Bastien JI; McNeill KA; Fine HA
Cancer; 2015 Feb; 121(4):502-16. PubMed ID: 25250735
[TBL] [Abstract][Full Text] [Related]
22. Therapeutic strategies for inhibiting invasion in glioblastoma.
Drappatz J; Norden AD; Wen PY
Expert Rev Neurother; 2009 Apr; 9(4):519-34. PubMed ID: 19344303
[TBL] [Abstract][Full Text] [Related]
23. Mitochondrial energy metabolism and apoptosis regulation in glioblastoma.
Nagy A; Eder K; Selak MA; Kalman B
Brain Res; 2015 Jan; 1595():127-42. PubMed ID: 25451120
[TBL] [Abstract][Full Text] [Related]
24. Next-generation molecular genetics of brain tumours.
Suvà ML; Louis DN
Curr Opin Neurol; 2013 Dec; 26(6):681-7. PubMed ID: 24184972
[TBL] [Abstract][Full Text] [Related]
25. Molecular pathways in the formation of gliomas.
von Deimling A; Louis DN; Wiestler OD
Glia; 1995 Nov; 15(3):328-38. PubMed ID: 8586467
[TBL] [Abstract][Full Text] [Related]
26. Age and TP53 mutation frequency in childhood malignant gliomas: results in a multi-institutional cohort.
Pollack IF; Finkelstein SD; Burnham J; Holmes EJ; Hamilton RL; Yates AJ; Finlay JL; Sposto R;
Cancer Res; 2001 Oct; 61(20):7404-7. PubMed ID: 11606370
[TBL] [Abstract][Full Text] [Related]
27. Characterization of genes with increased expression in human glioblastomas.
Kavsan V; Shostak K; Dmitrenko V; Zozulya Y; Rozumenko V; Demotes-Mainard J
Tsitol Genet; 2005; 39(6):37-49. PubMed ID: 16396319
[TBL] [Abstract][Full Text] [Related]
28. Dominant-negative mutations of the tumor suppressor p53 relating to early onset of glioblastoma multiforme.
Marutani M; Tonoki H; Tada M; Takahashi M; Kashiwazaki H; Hida Y; Hamada J; Asaka M; Moriuchi T
Cancer Res; 1999 Oct; 59(19):4765-9. PubMed ID: 10519380
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic advances in the treatment of glioblastoma: rationale and potential role of targeted agents.
Reardon DA; Wen PY
Oncologist; 2006 Feb; 11(2):152-64. PubMed ID: 16476836
[TBL] [Abstract][Full Text] [Related]
30. Understanding glioblastoma tumor biology: the potential to improve current diagnosis and treatments.
Kesari S
Semin Oncol; 2011 Dec; 38 Suppl 4():S2-10. PubMed ID: 22078644
[TBL] [Abstract][Full Text] [Related]
31. Upregulating mutations in the TERT promoter commonly occur in adult malignant gliomas and are strongly associated with total 1p19q loss.
Arita H; Narita Y; Fukushima S; Tateishi K; Matsushita Y; Yoshida A; Miyakita Y; Ohno M; Collins VP; Kawahara N; Shibui S; Ichimura K
Acta Neuropathol; 2013 Aug; 126(2):267-76. PubMed ID: 23764841
[TBL] [Abstract][Full Text] [Related]
32. Gene therapeutics: the future of brain tumor therapy?
Cutter JL; Kurozumi K; Chiocca EA; Kaur B
Expert Rev Anticancer Ther; 2006 Jul; 6(7):1053-64. PubMed ID: 16831077
[TBL] [Abstract][Full Text] [Related]
33. IDH1 mutations is prognostic marker for primary glioblastoma multiforme but MGMT hypermethylation is not prognostic for primary glioblastoma multiforme.
Kalkan R; Atli Eİ; Özdemir M; Çiftçi E; Aydin HE; Artan S; Arslantaş A
Gene; 2015 Jan; 554(1):81-6. PubMed ID: 25455102
[TBL] [Abstract][Full Text] [Related]
34. [Presence of glioblastoma multiforme in 3 sisters aged 50 to 54 years (recent observations on the etiology of dysontogenetic tumors)].
KOCH G; MIDDENDORF E
Med Welt; 1960 Nov; 48():2541-4. PubMed ID: 13757323
[No Abstract] [Full Text] [Related]
35. Current concepts in the molecular genetics of pediatric brain tumors: implications for emerging therapies.
Tamber MS; Bansal K; Liang ML; Mainprize TG; Salhia B; Northcott P; Taylor M; Rutka JT
Childs Nerv Syst; 2006 Nov; 22(11):1379-94. PubMed ID: 16951964
[TBL] [Abstract][Full Text] [Related]
36. Molecular biology of pediatric brain tumors and impact on novel therapies.
Hoffman LM; Salloum R; Fouladi M
Curr Neurol Neurosci Rep; 2015 Apr; 15(4):10. PubMed ID: 25690927
[TBL] [Abstract][Full Text] [Related]
37. Morphologic and Molecular Aspects of Glioblastomas.
Lopes Abath Neto O; Aldape K
Neurosurg Clin N Am; 2021 Apr; 32(2):149-158. PubMed ID: 33781498
[TBL] [Abstract][Full Text] [Related]
38. Innovations in Neuro-Oncology.
Magge RS; Barbaro M; Fine HA
World Neurosurg; 2021 Jul; 151():386-391. PubMed ID: 34243672
[TBL] [Abstract][Full Text] [Related]
39. Tumor profiling: development of prognostic and predictive factors to guide brain tumor treatment.
Settle SH; Sulman EP
Curr Oncol Rep; 2011 Feb; 13(1):26-36. PubMed ID: 21082294
[TBL] [Abstract][Full Text] [Related]
40. Defining the Immune Phenotype for Glioblastoma Multiforme: One Step Closer to Understanding Our Enemy.
Rahme RJ; Aoun RJ; Pines AR; Swanson KR; Bendok BR
World Neurosurg; 2016 Nov; 95():576-577. PubMed ID: 27565464
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
